Please login to the form below

Not currently logged in
Email:
Password:

Emer Cooke appointed EMA’s head of international and European cooperation

Will lead Agency’s efforts to develop relationships with both EU and non-EU bodies

Emer Cooke - EMAThe European Medicines Agency (EMA) has appointed Emer Cooke to the position of head of international and European cooperation.

She had held the role on an acting basis since its creation in February, 2012, and now takes up the position formally.

Cooke will be tasked with developing, coordinating and implementing the Agency's international strategy and activities, including confidentiality arrangements with countries outside the European Union (EU), such as the US, Japan and Canada.

She will also lead the sector's efforts in managing the EMA's relationship with EU institutions and bodies, including heads of national medicines agencies.

Cooke has been with the EMA since 2002, initially joining as head of inspections before being appointed international liaison officer.

Prior to this, she was enterprise directorate general at the European Commission in Brussels.

18th July 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Watermeadow Medical

Watermeadow Medical is an award-winning, international agency with offices in Oxford and Manchester, UK and New York, USA. ....

Latest intelligence

BL_Where_Now_20140721_CoverImage.jpg
3 Steps to Navigating Multichannel in Healthcare
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign....
Online Physician Communities
How can pharma develop a more customer-centric approach?
Business pressures and customer needs will force pharma to focus on multichannel marketing in the next few years...
Exploring MINT: Part 2 - Indonesia
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...